The story so far: Serevent (salmeterol xinafoate) is a beta-agonist inhaler for asthmatics. Deaths were so quickly associated with the drug following its approval that the manufacturer, GlaxoSmithKline (GSK),
Asthma sufferers are more than three times as likely to die from an attack if they have taken a major tranquillizer in the previous 12 months.